Speeches

A Comment on Merger Enforcement in the United States and in the European Union

Prepared Remarks before the Transatlantic Business Dialogue Principals Meeting

Washington, D.C.

Date:
By: 
Thomas B. Leary, Former Commissioner

The following is a purely personal comment on the current controversy over merger enforcement in the United States and in Europe. It is particularly important to emphasize here that I speak only for myself and not for my agency or anyone else in it.

Protecting Consumers' Privacy: 2002 and Beyond

Remarks at The Privacy 2001 Conference

Cleveland, Ohio

Date:
By: 
Timothy J. Muris, Former Chairman

*The views expressed are those of the Chairman, and do not necessarily reflect the views of the Commission or of any other Commissioner. In his delivered remarks, the Chairman may deviate frequently from the printed text of the speech.

One World, One Privacy

The 23d International Conference of Data Protection Commissioners, Paris, La Sorbonne

Date:
By: 
Mozelle W. Thompson, Former Commissioner

Good morning. Thank you Professor Rodota; and I'd also like to thank CNIL for inviting me to speak here today. At the outset, I'd like to make a few comments about the events of September 11.

On behalf of the people of the United States and as a representative of the US government, I would like to thank all of you for your expressions of sympathy and support. I would also like to particularly thank the people of France and our hosts, CNIL, for their continued demonstration of the history of closeness and fraternity our countries have enjoyed.

Remarks

National POW/MIA Recognition Day, Arlington National Cemetery

Date:
By: 
Orson Swindle, Former Commissioner

Distinguished Guests, Families and Friends ....

I am always concerned that I will overlook someone deserving of recognition, forgive me if I have done so today. Most certainly, all here deserve recognition.

With the awesome responsibilities that our government and military leaders have before them, I know that I can express for the families and friends of those Missing in Action an enormous sense of gratitude for your being here.

The Case for Standardization of Privacy Policy Formats

Article written July 2001

Date:
By: 
Sheila F. Anthony, Former Commissioner

* Commissioner Anthony's remarks are adapted from several speeches she has made on consumer privacy. The views expressed are those of Commissioner Anthony and do not necessarily reflect the views of the Federal Trade Commission or any other individual Commissioner. The author gratefully acknowledges the assistance of her Attorney Advisor, Katherine Armstrong, in preparation of this article.

Remarks

To the Customer Relationship Education Project Dialogue, Center for Information Policy Leadership at Hunton & Williams

Atlanta, Georgia

Date:
By: 
Orson Swindle, Former Commissioner

Good evening. I will begin with the traditional announcement that as a Commissioner of the Federal Trade Commission (FTC), I speak only for myself, and my remarks do not necessarily represent the views of either the FTC or any other Commissioner.

Robert Pitofsky: Public Servant and Scholar

The Second Annual Conference, American Antitrust Institute

Washington, D.C.

Date:
By: 
Timothy J. Muris, Former Chairman

Robert Pitofsky is one of the key Founding Fathers of the modern FTC. He was present at its creation, as principal author of the 1969 ABA Report on the Commission.(1) In that pivotal role, he crafted a vision for a revitalized agency that remains as relevant today as it was 30 years ago. The core of that vision is the recognition that consumer welfare is the agency's reason for being. Even more remarkably, over the next three decades, Bob, in his role as BCP Director, Commissioner, and Chairman, as well as scholar, worked to make that vision a reality.

Antitrust Issues in the Settlement of Pharmaceutical Patent Disputes, Part II

The American Bar Association Antitrust Healthcare Program, in Washington, D.C., on May 17, 2001, and to be published in the December 2001 edition of the Journal of Health Law

Date:
By: 
Thomas B. Leary, Former Commissioner

As the title indicates, the settlement of pharmaceutical patent disputes is a subject that I have already addressed.(1) You may wonder why I am visiting it again. When I first discussed the issue last November, The Federal Trade Commission ("the Commission") had brought only two cases,(2) with a few more in the pipeline.

State Auto Dealer Regulation: One Man's Preliminary View

The International Franchise Association 34th Annual Legal Symposium

Washington, D.C.

Date:
By: 
Thomas B. Leary, Former Commissioner

The title of this speech should be taken literally. The reference to one man emphasizes that I am just speaking for myself. This is the standard disclaimer from people in a federal agency, but I flag it here because this article addresses something that I have not even discussed with my colleagues in the Commission. State auto dealer regulation is a subject that I have been thinking about recently, but thus far I have been doing so in isolation.

The Patent-Antitrust Interface

Based on a speech before the American Bar Association's Section of Antitrust Law Program, "Intellectual Property and Antitrust: Navigating the Minefield"

Philadelphia, Pennsylvania

Date:
By: 
Thomas B. Leary, Former Commissioner

I. Introduction

The interface between intellectual property law and competition is a challenging subject that is a relatively new one for me. For a variety of reasons my individual private practice did not focus on patent antitrust issues.

The Midwest Gasoline Investigation

The University of Maryland

College Park, Maryland

Date:
By: 
Jeremy Bulow, Former Director

The FTC's investigation of the Midwest Gasoline price spike found no evidence of any anti-trust violations. In my view the main culprit was the introduction of Phase II reformulated gasoline and the adjustment to that new requirement, particularly in the Chicago and Milwaukee area, where refiners use ethanol rather than MTBE in reformulated gasoline (RFG). 

Between Competition and Cooperation--Changing Business-to-Business Relations

The 8th World Business Dialogue, University of Cologne

Cologne, Germany

Date:
By: 
Orson Swindle, Former Commissioner

Introduction and Disclaimer

Good morning. I am very pleased to have an opportunity to participate in a discussion of a number of issues of international interest.

Some of the topics I will briefly touch on include the U.S. Federal Trade Commission's international enforcement activities -- especially as to mergers and electronic commerce -- and the growth of transnational antitrust cooperation as a way of dealing with anticompetitive activities that have cross-border effects.

Report from the Bureau of Competition

The American Bar Association, Antitrust Section, Spring Meeting 2001

Washington, D.C.Ê

Date:
By: 
Molly S. Boast, Former Director

I. Introduction

I appreciate the opportunity to present this overview of developments at the Bureau of Competition over the last twelve months.(1) I have the distinct honor of succeeding Rich Parker, who presented the Bureau's report last year. As illustrated by the Bureau's record during his tenure, I have large shoes to fill (or, in his case, cowboy boots). Fortunately, Rich left a Bureau with a highly talented and dedicated staff focused on serving the public interest.

Washington State Senate: Identity Theft Statement

The Committe on Labor, Commerce and Financial Institutions, Washington State Senate

Olympia, Washington

Date:
By: 
Charles Harwood, Former Deputy Director

Senator Prentice and members of the Committee, I am Charles Harwood, Director of the Northwest Region of the Federal Trade Commission ("FTC" or "Commission").(1) I appreciate the opportunity to present testimony on the important issue of identity theft, and to describe the Commission's efforts to help victims, alert industry and equip law enforcement to deal with this harrowing crime.(2)

Antitrust Economics: Three Cheers and Two Challenges

Date:
By: 
Thomas B. Leary, Former Commissioner

People who labor in and around the law are naturally wary of commentary that begins with praise. They have learned, for example, that appellate court opinions that start with references to the "learned" or "distinguished" trial judge invariably are reversals. And a lifetime of exposure to parental guidance, lectures, sermons and other forms of address suggest that praise is often a prelude to complaint.

Antitrust Issues in Settlement of Pharmaceutical Patent Disputes

Sixth Annual Health Care Antitrust Forum, Northwestern University School of Law

Chicago, Illinois

Date:
By: 
Thomas B. Leary, Former Commissioner

1. Introduction

I want to thank the Healthcare Antitrust Forum for the invitation to talk about some recent developments in healthcare antitrust at the FTC.(1) An agency representative's usual response to such an invitation is a survey of cases across a spectrum, but I will not do that today. Instead, I would like to focus in some depth on the antitrust issues involved in the settlement of pharmaceutical patent disputes.

Pages